Navigation Links
Jonathan Jacobson Appointed General Manager, Global Business Strategies & Operations, Menicon Co., Ltd.
Date:11/10/2008

NAGOYA, Japan, Nov. 10 /PRNewswire/ -- He will play a vital role in Menicon's expansion in the world's contact lens

market.

Menicon Co., Ltd. announced the appointment of Jonathan Jacobson as General Manager, Global Business Strategies & Operations, effective November 10. Jacobson joined Menicon after serving at Bausch & Lomb for 23 years. During this time, Jacobson held many different executive positions including Director of Marketing, Director of International Sales, and Director of International Business for Polymer Technology Corporation. He also acted as Director of GP Business for Bausch & Lomb in Europe. For the last 8 years, Jacobson had been the Director of Global GP Business for Bausch & Lomb.

(Photo: http://www.newscom.com/cgi-bin/prnh/20081110/NY44669)

He has strong expertise in international business and sales force management, market development and distributor operations. He has also demonstrated outstanding skills in project management, strategic planning and the introduction of new products.

Jacobson will be based in the USA while being responsible for the company's business strategies & operations throughout the world including the recently acquired Rose-K business.

Toshio Matsushima, Senior Executive Officer for Menicon Co., Ltd., commented: "We are extremely happy to welcome Jacobson on board. Jacobson, with his exceptional knowledge of and experience in the global contact lens business and strong leadership qualities, is now a key player in our organization and will play a leading role in expanding our business worldwide. We are really privileged and fortunate to have him on the global Menicon team."

Jacobson, Menicon's new General Manager, Global Business Strategies & Operations, commented: "It has been a great and rewarding experience working for Polymer Technology/Bausch & Lomb for nearly 24 years; however, now is a good time for change. I am very excited to be joining this growing and dynamic multinational company. I look forward to the new challenges of working with Menicon's team to expand the company's presence in the global contact lens market."

About Menicon:

Menicon Co., Ltd. (http://www.menicon.com), founded by Kyoichi Tanaka in 1951, is Japan's first and largest contact lens manufacturer, and now is represented in over 30 countries. Menicon is a manufacturer dedicated to all areas of soft and GP contact lens-related businesses including material development, lens designing, manufacturing of contact lenses, and care solutions. Menicon is a world leader in the development of hyper-Dk GP (Menicon Z) and soft contact lenses (Menicon PremiO).

Contact:

Toshio Matsushima

Global Business Operations

Menicon Co., Ltd.

Phone: +81-52-937-5021

Fax: +81-52-935-1121

E-mail: matsushima@menicon-net.co.jp

URL: http://www.menicon.com

Image Attachments Links:

http://asianetnews.net/ViewImage.asp?ID=111616


'/>"/>
SOURCE Menicon Co., Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Jailed Indian Pediatrician Wins 2008 Jonathan Mann Award for Global Health and Human Rights
2. Wisconsin Farmer Ronald Kusiak Honored With 2008 Jacobson Memorial Award
3. Courage Center Seeks Applications for Judd Jacobson Memorial Award
4. Mobile Imaging Innovator, Mobile Diagnostic Centers LP, Appoints New CEO : Mobile Imaging Development's Limited Partnership, Mobile Diagnostic Centers LP. Has Appointed Patrick McNamara as CEO
5. Esteemed Emergency Medicine Physician Appointed to TeleHealth World Magazine Editorial Advisory Board
6. Stuart Chesky, DO, JD, Ohio KePRO Medical Director, Appointed to Ohio Joint Legislative Study Commission on Most Favored Nation Clauses in Health Care Contracts
7. Midlothian Resident Katherine McCary Appointed by President Bush to National Council on Disability
8. Milton Frank Appointed COO of Life Recovery Systems
9. Breast-Conserving Surgery Leaves Many Cancer Patients Disappointed
10. H. Kim Lyerly appointed to the National Cancer Advisory Board
11. AARP Disappointed by U.S. Senate Vote to Block Medicare Improvement Bill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... Washington, DC (PRWEB) , ... ... ... the Siemens Foundation today announced a new initiative—the Siemens Foundation-PATH Ingenuity Fellowships—to ... settings. The partnership will recruit top students from U.S. universities who will ...
(Date:2/12/2016)... Boca Raton, FL (PRWEB) , ... February 12, ... ... nation’s largest non-profit organization devoted exclusively to funding innovative lymphoma research and serving ... patient services – hosted over 250 members of South Florida’s philanthropic community at ...
(Date:2/12/2016)... ... February 12, 2016 , ... CDRH Enforcement Trends: , Back to the Future , ... , As Winston Churchill said, “Those who don’t learn from history are doomed to ... expect when they come knocking this year. But that takes time. , Take a ...
(Date:2/12/2016)... ... February 12, 2016 , ... Fixed Dose Combination ... 3:00 p.m. EST, http://www.fdanews.com/fixeddosecombination , Fixed dose combination ... garnering increased attention from all stakeholders in the development of new chemical entities. ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... Each year, ... will be held in Anaheim, CA at the Anaheim Convention Center. Almost 10,000 physical ... see new therapy products in action, learn more about their chosen field and network ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... Va. , Feb. 12, 2016   National ... Hoey , RPh, MBA issued the following statement today ... released by the Centers for Medicare & ... raised by NCPA, beneficiary advocates and others: ... raised. We are still reviewing the full CMS analysis. ...
(Date:2/12/2016)...  This month,s issue of the Journal of ... in-depth look at various causes and consequences associated with rising health ... which has generated significant public outrage and calls for ... E. Happe , PharmD, MPH. --> JMCP ... --> In 2014 prescription drug spending in ...
(Date:2/12/2016)... PAULO , Feb. 12, 2016 ... commenced a cash tender offer (the "Tender Offer") ... million outstanding aggregate principal amount of its 6.500% ... and ISIN Nos. US44915JAA88/ USP5246AAF05) (the "Notes"). In ... soliciting (the "Consent Solicitation") consents (the "Consents") of ...
Breaking Medicine Technology: